MyFinsight
Home
Blog
About
Short-term investments
$206,396,805
(971.29%↑ Y/Y)
Cash and cash
equivalents
$11,334,370
(737.50%↑ Y/Y)
Prepaid expenses
$1,297,590
(173.39%↑ Y/Y)
Other receivable
$10,912
Total current assets
$219,039,677
(938.39%↑ Y/Y)
Other assets
$19,500
(-11.26%↓ Y/Y)
Total assets
$219,059,177
(937.40%↑ Y/Y)
Total liabilities and
stockholders equity
$219,059,177
(937.40%↑ Y/Y)
Total stockholders
equity
$206,558,323
(1195.08%↑ Y/Y)
Total liabilities
$12,500,854
(141.95%↑ Y/Y)
Accumulated deficit
-$730,233,339
(-9.27%↓ Y/Y)
Additional paid-in capital
$936,684,992
(36.90%↑ Y/Y)
Total current
liabilities
$7,420,773
(44.53%↑ Y/Y)
Stock appreciation
rights
$5,080,081
(15717.91%↑ Y/Y)
Common stock, 0.001 par
value, 200,000,000...
$106,670
(221.38%↑ Y/Y)
Accrued expenses
$5,011,583
(32.84%↑ Y/Y)
Accounts payable
$2,409,190
(76.90%↑ Y/Y)
Back
Back
Balance Sheet
RELMADA THERAPEUTICS, INC. (RLMD)
RELMADA THERAPEUTICS, INC. (RLMD)
source: myfinsight.com